Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (41-50 of 587) with videos related to

Pageof 59
Sort By:
Modern Problems of Pharmacopsychiatry|January 1, 1983
Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implicationsG P Reynolds, P Riederer
Current Opinion in Neurology and Neurosurgery|June 1, 1992
Pathogenesis of Parkinson's diseaseP Riederer, K W Lange
Journal of Neurochemistry|May 1, 1986
Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenylP Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1985
Increased synaptic markers in hippocampus of depressed patientsO S Jørgensen, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|February 28, 2012
The significance of neuronal lateralisation in Parkinson's diseaseP Riederer, J Sian-Hülsmann
Journal of Neural Transmission|January 1, 1981
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brainG P Reynolds, P Riederer
International Pharmacopsychiatry|January 1, 1981
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effectsG P Reynolds, P Riederer
Journal of Chromatography|September 11, 1981
Determination of a wide range of urinary amine metabolites using a simple high-performance liquid chromatographic techniqueP Riederer, G P Reynolds
Neurochemistry International|May 27, 2010
MPTP induced dopaminergic neurotoxicity-a useful model in the study of parkinson's disease?P Riederer, M B Youdim
Pharmacological Research Communications|December 1, 1988
Monoamine oxidase B; a misunderstood and misjudged enzymeM B Youdim, P Riederer
Pageof 59

Showing results (41-50 of 587) with videos related to

Sort By:
Pageof 59
Modern Problems of Pharmacopsychiatry|January 1, 1983
Assessment of MAO inhibitors using postmortem human brain tissue: biochemical and therapeutic implicationsG P Reynolds, P Riederer
Current Opinion in Neurology and Neurosurgery|June 1, 1992
Pathogenesis of Parkinson's diseaseP Riederer, K W Lange
Journal of Neurochemistry|May 1, 1986
Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenylP Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1985
Increased synaptic markers in hippocampus of depressed patientsO S Jørgensen, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|February 28, 2012
The significance of neuronal lateralisation in Parkinson's diseaseP Riederer, J Sian-Hülsmann
Journal of Neural Transmission|January 1, 1981
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brainG P Reynolds, P Riederer
International Pharmacopsychiatry|January 1, 1981
Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effectsG P Reynolds, P Riederer
Journal of Chromatography|September 11, 1981
Determination of a wide range of urinary amine metabolites using a simple high-performance liquid chromatographic techniqueP Riederer, G P Reynolds
Neurochemistry International|May 27, 2010
MPTP induced dopaminergic neurotoxicity-a useful model in the study of parkinson's disease?P Riederer, M B Youdim
Pharmacological Research Communications|December 1, 1988
Monoamine oxidase B; a misunderstood and misjudged enzymeM B Youdim, P Riederer
Pageof 59